FDA inspection
Shilpa Medicare Limited: FDA inspection ending Jul 28, 2017
FDA inspection 1020609 · No Action Indicated (NAI) · Jadcherla, Mahabubnagar District
Key facts
| Inspection ID | 1020609 |
|---|---|
| Firm | Shilpa Medicare Limited |
| FEI number | 3009876430 |
| Address | S-20 To S-26, Pharm. Formulation Sez, Tsiic, Green Industrial Park |
| City | Jadcherla, Mahabubnagar District |
| Country | India |
| Fiscal year | 2017 |
| Inspection end date | Jul 28, 2017 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data